Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers.

Immunity · 2019 · PMC6335502 · PMID 30552025

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The differences in both BG505 S375Y pseudovirus as well as SHIV BG505 challenge stock neutralization ID 50 titers between high and low nAb titer animals at week −2 were, as anticipated, highly significant ( Figures 1 B and 1C).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.